Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Pfizer

Status: Terminated

Conditions: Hypertension

Treatments: Drug: Amlodipine + Olmesartan medoxomil

Study type: Observational

Funder types: Industry

Identifiers

NCT01200407

B1581001

Details and patient eligibility

About

The purpose of this study is to determine the safety, tolerability and efficacy of Amlodipine and Olmesartan medoxomil among Hypertensive Filipino patients.

Enrollment: 615 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Filipino hypertensive subjects ages 18-65 years old whether naive or currently taking any other anti-hypertensive or those on monotherapy using CCBs or ARBs whom they want to shift on a fixed dose combination drug

Exclusion criteria

• Patients with contraindications to any of the component of the fixed drug (amlodipine or olmesartan medoxomil) or with malignant or secondary hypertension

Trial design

615 participants in 1 patient group

Filipino Hypertensive patients

Description:

Male and Female, 18 to 65 year old Filipino hypertensive patients prescribed by their doctors with Normetec

Treatment:

Drug: Amlodipine + Olmesartan medoxomil